PONATINIB

Overview

PONATINIB is a Schedule H drug.
Ponatinib is a cancer medicine that interferes with the growth of some cancer cells. Ponatinib is used to treat a type of blood cancer called chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). Ponatinib is usually given after other similar medications have been tried without success.

Usage

PONATINIB is generally used to treat: Leukemia, Myeloid, Acute Lymphoblastic Leukemia

Frequently Asked Questions

Q: Is it safe on my liver?
A: Check with your Doctor first

Q: Is it safe on my kidney?
A: Check with your Doctor first

Q: Can I take it with alcohol?
A: Not Safe

Q: Is it safe for children?
A: Ask your doctor

Q: Can it be taken during pregnancy?
A: Studies indicate Risk – Doctor advice is must

How Do I Take It?

Route of Administration: Oral

Precautions

Caution should be exercised in patients with the history of blood clots, heart, liver or kidney problems, pancreatitis, high blood pressure, bleeding problems, any allergy, who are taking other medications, during pregnancy and breastfeeding. Monitor complete blood count, patients for fluid retention, heart rhythm, blood pressure, signs and symptoms of heart failure regularly while taking this medication. Ensure adequate hydration otherwise it may lead to dehydration.

Symptoms of Overdosage

PONATINIB over-dosage can result in: Difficulty Breathing

Common Side-Effects

PONATINIB : Congestive Heart Disease, Pleural Effusion, Edema, Gastrointestinal Bleeding, Hypertension, Peripheral Neuropathy, Xerophthalmia, Myocardial Infarction, Pancreatitis, Tachycardia, Gums Bleeding, Eyes Blurred Vision, Dizziness, Rapid Heart Rate (pulse), Throat Soreness, Anxiety

Serious Side-Effects

PONATINIB : Eyes Blurred Vision, Weight Gain, Eyes Pain, Blood Or Red Colored Urine, Seizures (uncontrollable Jerking Of Limbs), Shortness Of Breath

Rare Side-Effects

PONATINIB : Skin Rash, Face Swelling, Dizziness, Difficulty Breathing

Disease Interactions

PONATINIB can interfere with: Congestive Heart Disease, Pleural Effusion, Edema

Technical Classification

PONATINIB is categorized as:

• BCR-ABL TYROSINE KINASE INHIBITORS / ANTINEOPLASTICS
• MULTIKINASE INHIBITORS / ANTINEOPLASTICS
• VEGF/VEGFR INHIBITORS / ANTINEOPLASTICS

Storage Conditions

Room Temperature (Between 15 To 25 C)

Available Alternatives

What are the other drugs with similar Ingredients?

PONATINIB

PONATINIB